# Grifols Biomat, INC – FDA Inspection, May 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/grifols-biomat-inc/08eb839d-a580-40af-950c-cfe90e3f2c8f
Source feed: FDA_Inspections

> FDA inspection 1316578 of Grifols Biomat, INC, May 11, 2026. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1316578
- Company Name: Grifols Biomat, INC
- Inspection Date: 2026-05-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Florida District Office
- Citation Count: 1

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/steen-n-graham/e0ce4c37-b1f1-4d94-8071-2d89b74975fd)

Company: https://www.keypedia.com/companies/grifols-biomat-inc/a3a68850-9bb0-4a84-8121-c29b3a23c3f9

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9